227 related articles for article (PubMed ID: 12548530)
1. Early prednisone treatment in Duchenne muscular dystrophy.
Merlini L; Cicognani A; Malaspina E; Gennari M; Gnudi S; Talim B; Franzoni E
Muscle Nerve; 2003 Feb; 27(2):222-7. PubMed ID: 12548530
[TBL] [Abstract][Full Text] [Related]
2. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
[TBL] [Abstract][Full Text] [Related]
3. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial.
Beenakker EA; Fock JM; Van Tol MJ; Maurits NM; Koopman HM; Brouwer OF; Van der Hoeven JH
Arch Neurol; 2005 Jan; 62(1):128-32. PubMed ID: 15642859
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
[TBL] [Abstract][Full Text] [Related]
5. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up.
Merlini L; Gennari M; Malaspina E; Cecconi I; Armaroli A; Gnudi S; Talim B; Ferlini A; Cicognani A; Franzoni E
Muscle Nerve; 2012 Jun; 45(6):796-802. PubMed ID: 22581531
[TBL] [Abstract][Full Text] [Related]
6. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.
ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT
Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890
[TBL] [Abstract][Full Text] [Related]
7. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.
Connolly AM; Schierbecker J; Renna R; Florence J
Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone in Duchenne muscular dystrophy.
Rahman MM; Hannan MA; Mondol BA; Bhoumick NB; Haque A
Bangladesh Med Res Counc Bull; 2001 Apr; 27(1):38-42. PubMed ID: 11692899
[TBL] [Abstract][Full Text] [Related]
9. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
[TBL] [Abstract][Full Text] [Related]
10. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
[TBL] [Abstract][Full Text] [Related]
11. A novel treatment regimen for Duchenne muscular dystrophy.
Li M; Cai Y; Zhong M; Zou L; Gong C
Neuroreport; 2013 Nov; 24(16):924-7. PubMed ID: 24045777
[TBL] [Abstract][Full Text] [Related]
12. CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophy.
Buyse GM; Goemans N; Henricson E; Jara A; van den Hauwe M; Leshner R; Florence JM; Mayhew JE; Escolar DM
Eur J Paediatr Neurol; 2007 Nov; 11(6):337-40. PubMed ID: 17459739
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.
Biggar WD; Harris VA; Eliasoph L; Alman B
Neuromuscul Disord; 2006 Apr; 16(4):249-55. PubMed ID: 16545568
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy.
Lit L; Sharp FR; Apperson M; Liu DZ; Walker WL; Liao I; Xu H; Ander BP; Wong B
Pharmacogenomics J; 2009 Dec; 9(6):411-8. PubMed ID: 19488064
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
Mendell JR; Moxley RT; Griggs RC; Brooke MH; Fenichel GM; Miller JP; King W; Signore L; Pandya S; Florence J
N Engl J Med; 1989 Jun; 320(24):1592-7. PubMed ID: 2657428
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Navarro FA; Hanauer SB; Kirschner BS
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
[TBL] [Abstract][Full Text] [Related]
17. Daily prednisone treatment in Duchenne muscular dystrophy in southwest China.
Hu J; Ye Y; Kong M; Hong S; Cheng L; Wang Q; Qin J; Zou L; Jiang L
Muscle Nerve; 2015 Dec; 52(6):1001-7. PubMed ID: 25809413
[TBL] [Abstract][Full Text] [Related]
18. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy.
King WM; Ruttencutter R; Nagaraja HN; Matkovic V; Landoll J; Hoyle C; Mendell JR; Kissel JT
Neurology; 2007 May; 68(19):1607-13. PubMed ID: 17485648
[TBL] [Abstract][Full Text] [Related]
19. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
Duboc D; Meune C; Lerebours G; Devaux JY; Vaksmann G; Bécane HM
J Am Coll Cardiol; 2005 Mar; 45(6):855-7. PubMed ID: 15766818
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
